Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Iqvia Holdings Inc (IQV)

Iqvia Holdings Inc (IQV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 34,760,880
  • Shares Outstanding, K 181,500
  • Annual Sales, $ 14,984 M
  • Annual Income, $ 1,358 M
  • EBIT $ 3,204 M
  • EBITDA $ 4,347 M
  • 60-Month Beta 1.49
  • Price/Sales 2.31
  • Price/Cash Flow 12.13
  • Price/Book 4.97

Options Overview Details

View History
  • Implied Volatility 30.52% ( -0.66%)
  • Historical Volatility 27.78%
  • IV Percentile 73%
  • IV Rank 51.13%
  • IV High 40.05% on 10/22/24
  • IV Low 20.55% on 03/20/24
  • Put/Call Vol Ratio 0.46
  • Today's Volume 127
  • Volume Avg (30-Day) 1,166
  • Put/Call OI Ratio 2.37
  • Today's Open Interest 17,261
  • Open Int (30-Day) 13,885

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 22 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 2.87
  • Number of Estimates 8
  • High Estimate 2.91
  • Low Estimate 2.82
  • Prior Year 2.65
  • Growth Rate Est. (year over year) +8.30%

Price Performance

See More
Period Period Low Period High Performance
1-Month
188.87 +4.45%
on 12/19/24
210.02 -6.07%
on 12/10/24
+2.89 (+1.49%)
since 11/20/24
3-Month
187.62 +5.14%
on 11/18/24
245.20 -19.55%
on 09/23/24
-44.85 (-18.52%)
since 09/20/24
52-Week
187.62 +5.14%
on 11/18/24
261.73 -24.63%
on 03/08/24
-27.73 (-12.32%)
since 12/20/23

Most Recent Stories

More News
Is IQVIA Holdings Stock Underperforming the Nasdaq?

IQVIA Holdings has considerably underperformed the Nasdaq over the past year, but analysts are highly optimistic about the stock’s prospects.

A : 134.51 (+0.99%)
$NASX : 19,572.60 (+1.03%)
IQV : 197.27 (+3.00%)
Do Wall Street Analysts Like IQVIA Holdings Stock?

IQVIA Holdings has underperformed the broader market over the past year, but Wall Street analysts are bullish about the stock’s prospects.

XLV : 138.00 (+1.26%)
$SPX : 5,930.85 (+1.09%)
IQV : 197.27 (+3.00%)
Stocks Settle Mostly Higher on Tech Stock Strength and Lower Bond Yields

The S&P 500 Index ($SPX ) (SPY ) Monday closed up +0.39%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.13%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.71%. Stocks on Monday...

NVDA : 134.70 (+3.08%)
HSIC : 69.82 (+1.26%)
$SPX : 5,930.85 (+1.09%)
SMCI : 31.59 (+1.12%)
FOUR : 103.52 (+2.23%)
NKE : 76.94 (-0.21%)
OKTA : 83.28 (+1.95%)
$IUXX : 21,289.15 (+0.85%)
IQV : 197.27 (+3.00%)
QQQ : 518.66 (+0.87%)
ZNH25 : 108-310s (+0.33%)
TSLA : 421.06 (-3.46%)
Stocks Mostly Higher on Positive Corporate News

The S&P 500 Index ($SPX ) (SPY ) today is up +0.43%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.01%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.91%. Stocks today are mostly higher...

NVDA : 134.70 (+3.08%)
$SPX : 5,930.85 (+1.09%)
SMCI : 31.59 (+1.12%)
FOUR : 103.52 (+2.23%)
NKE : 76.94 (-0.21%)
$IUXX : 21,289.15 (+0.85%)
IQV : 197.27 (+3.00%)
QQQ : 518.66 (+0.87%)
ZNH25 : 108-310s (+0.33%)
TSLA : 421.06 (-3.46%)
NGNE : 22.64 (+2.56%)
NEM : 38.28 (+3.40%)
IQVIA: Q3 Earnings Snapshot

IQVIA: Q3 Earnings Snapshot

IQV : 197.27 (+3.00%)
IQVIA Holdings' Quarterly Earnings Preview: What You Need to Know

With IQVIA Holdings gearing up to release its third-quarter earnings later this month, analysts project a double-digit surge in earnings.

XLV : 138.00 (+1.26%)
$SPX : 5,930.85 (+1.09%)
IQV : 197.27 (+3.00%)
EPAM Expands With First Derivative Buyout: What Should Investors Do?

EPAM Systems EPAM has seen its share price plunge 35.3% year to date, underperforming the Zacks Computers - IT Services industry, Zacks Computer and Technology sector and the S&P 500’s return of 8.4%,...

MSFT : 436.60 (-0.10%)
EPAM : 248.26 (+0.59%)
CRM : 343.65 (+2.21%)
IQV : 197.27 (+3.00%)
Here's Why You Should Retain IQVIA Holdings Shares Now

IQVIA Holdings Inc. IQV has had an impressive run over the past three months. The stock has gained 9.3%, outperforming the 3.9% rise of the industry it belongs to and the Zacks S&P 500 composite’s 2%...

APP : 340.99 (+6.98%)
DOCU : 94.41 (+0.28%)
IQV : 197.27 (+3.00%)
Is Viking Therapeutics Stock a Buy?

The company is in the spotlight for one of its programs, but it's got others that also have promise.

VKTX : 42.25 (+1.83%)
LLY : 767.76 (+1.35%)
IQV : 197.27 (+3.00%)
Is Charles River Laboratories Stock Underperforming the Dow?

Charles River Laboratories underperformed the Dow recently, but Wall Street analysts remain moderately optimistic about the stock’s prospects.

$DOWI : 42,840.26 (+1.18%)
CRL : 185.77 (+1.99%)
IQV : 197.27 (+3.00%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

IQVIA Holdings Inc. provides advanced analytics, technology solutions and contract research services to the life sciences industry. The company was formed through the merger of IMS Health (RX) and Quintiles. The company is focused on helping healthcare clients to better serve patients by bringing in...

See More

Key Turning Points

3rd Resistance Point 209.83
2nd Resistance Point 204.98
1st Resistance Point 201.13
Last Price 197.27
1st Support Level 192.43
2nd Support Level 187.58
3rd Support Level 183.73

See More

52-Week High 261.73
Fibonacci 61.8% 233.42
Fibonacci 50% 224.68
Fibonacci 38.2% 215.93
Last Price 197.27
52-Week Low 187.62

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar